← Leaderboards
Kimberly A Yonkers
Yale University
$18,819,539
Attributed
$24,292,874
Total exposure
16
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$23,093,058 · 15
CDC$1,199,816 · 1
By mechanism
R01$18,623,551 · 7
R21$2,949,351 · 5
M01$1,320,334 · 2
R34$767,056 · 1
K08$632,582 · 1
Top collaborators
- Steve Martino11 shared
- Steven J Ondersma5 shared
- Mehmet Sofuoglu4 shared
- Vikki Abrahams2 shared
Most similar at Yale University
Same institution · by research overlap
- George B Richerson$18,281,692
- Nathan B Hansen$7,849,116
- Cameron Gettel$577,902
Others in their field
Top investigators on “Randomized”
- James Dennis Neaton · Northwestern University$305,243,252
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$292,521,996
- Lawrence Corey · Fred Hutchinson Cancer Center$292,521,996
- Marian Ewell · The Emmes Company, Llc$278,931,253
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$199,647,509
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
Research focus
RandomizedWomanCostResponseMotivationEffectivenessLeadPharmaceutical PreparationsClinical ResearchTrainingPregnancyHuman SubjectCounselingReportingScreening ProcedureBaseBehavioralPremenstrual SyndromeMedicalPreventionBrief InterventionAlcohol Or Other Drugs UseMenstrual CycleLiterature
Grant awards (57)
Development of a Text Intervention for Perinatal Depression$234,359
R34 · FY2024 · MH · contact PI
Scaling up: A multi-site trial of e-SBI for alcohol use in Pregnancy$496,906
R01 · FY2023 · AA
Development of a Text Intervention for Perinatal Depression$244,136
R34 · FY2023 · MH · contact PI
Scaling up: A multi-site trial of e-SBI for alcohol use in Pregnancy$523,813
R01 · FY2022 · AA
Development of a Text Intervention for Perinatal Depression$288,561
R34 · FY2022 · MH · contact PI
Scaling up: A multi-site trial of e-SBI for alcohol use in Pregnancy$527,390
R01 · FY2021 · AA
Mechanisms and prevention of preterm birth in women exposed to antidepressants during pregnancy$209,375
R21 · FY2021 · HD
Scaling up: A multi-site trial of e-SBI for alcohol use in Pregnancy$517,003
R01 · FY2020 · AA
Mechanisms and prevention of preterm birth in women exposed to antidepressants during pregnancy$251,250
R21 · FY2020 · HD
Scaling up: A multi-site trial of e-SBI for alcohol use in Pregnancy$579,754
R01 · FY2019 · AA
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient$693,236
R01 · FY2016 · DA
PRENATAL SUBSTANCE USE SCREENING: VALIDATION AND COMPARISON OF PROMISING MEASURES$599,908
R21 · FY2016 · DP · contact PI
Progesterone Augmentation for Smoking Cessation in Women$181,069
R21 · FY2016 · CA · contact PI
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient$8,467
R01 · FY2016 · DA
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient$712,849
R01 · FY2015 · DA
PRENATAL SUBSTANCE USE SCREENING: VALIDATION AND COMPARISON OF PROMISING MEASURES$599,908
R21 · FY2015 · DP · contact PI
Progesterone Augmentation for Smoking Cessation in Women$217,283
R21 · FY2015 · CA · contact PI
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient$741,746
R01 · FY2014 · DA
Project START: Screening to Augment Referral to Treatment$627,185
R01 · FY2014 · DA · contact PI
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient$743,038
R01 · FY2013 · DA
Project START: Screening to Augment Referral to Treatment$618,931
R01 · FY2013 · DA · contact PI
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient$784,966
R01 · FY2012 · DA
Project START: Screening to Augment Referral to Treatment$666,548
R01 · FY2012 · DA · contact PI
Project START: Screening to Augment Referral to Treatment$676,735
R01 · FY2011 · DA · contact PI
Symptom-Onset Antidepressant Treatment for PMDD$305,918
R01 · FY2011 · MH · contact PI
Progesterone for Postpartum Cocaine Relapse$240,803
R21 · FY2011 · DA · contact PI
Project START: Screening to Augment Referral to Treatment$721,449
R01 · FY2010 · DA · contact PI
Symptom-Onset Antidepressant Treatment for PMDD$312,933
R01 · FY2010 · MH · contact PI
Progesterone for Postpartum Cocaine Relapse$206,875
R21 · FY2010 · DA · contact PI
Symptom-Onset Antidepressant Treatment for PMDD$312,048
R01 · FY2009 · MH · contact PI
Effects of Perinatal Depression on PTD and LBW$646,458
R01 · FY2008 · HD · contact PI
Psychosocial Res. to Improve Drug Treatment in Pregnancy$448,816
R01 · FY2008 · DA · contact PI
Symptom-Onset Antidepressant Treatment for PMDD$310,102
R01 · FY2008 · MH · contact PI
Effects of Perinatal Depression on PTD and LBW$1,054,953
R01 · FY2007 · HD · contact PI
Psychosocial Res. to Improve Drug Treatment in Pregnancy$484,408
R01 · FY2007 · DA · contact PI
Symptom-Onset Antidepressant Treatment for PMDD$315,329
R01 · FY2007 · MH · contact PI
Effects of Perinatal Depression on PTD and LBW$1,056,890
R01 · FY2006 · HD · contact PI
Psychosocial Res. to Improve Drug Treatment in Pregnancy$484,345
R01 · FY2006 · DA · contact PI
Effects of Perinatal Depression on PTD and LBW$1,048,738
R01 · FY2005 · HD
Psychosocial Res. to Improve Drug Treatment in Pregnancy$481,557
R01 · FY2005 · DA
Effects of Perinatal Depression on PTD and LBW$828,117
R01 · FY2004 · HD
Psychosocial Res. to Improve Drug Treatment in Pregnancy$457,844
R01 · FY2004 · DA
ANXIETY, DISINHIBITION, AND RISK FOR DRUG ABUSE$224,777
R01 · FY2003 · DA
DETECTION AND TREATMENT OF POSTPARTUM DEPRESSION$164,769
K08 · FY2003 · MH
Treating PMS/PMDD--Research versus Clinical Reality$144,479
R21 · FY2003 · MH
EFFECT OF SEROTONIN DEPLETION IN SEVERE PREMENSTRUAL SYNDROME$321,374
M01 · FY2002 · RR
IS FLUOXETINES ANTIDYSPHORIC EFFECT MEDIATED BY NEUROSTEROIDS?$321,374
M01 · FY2002 · RR
DETECTION AND TREATMENT OF POSTPARTUM DEPRESSION$160,186
K08 · FY2002 · MH
Treating PMS/PMDD--Research versus Clinical Reality$144,663
R21 · FY2002 · MH
EFFECT OF SEROTONIN DEPLETION IN SEVERE PREMENSTRUAL SYNDROME$321,374
M01 · FY2001 · RR
IS FLUOXETINES ANTIDYSPHORIC EFFECT MEDIATED BY NEUROSTEROIDS?$321,374
M01 · FY2001 · RR
DETECTION AND TREATMENT OF POSTPARTUM DEPRESSION$155,974
K08 · FY2001 · MH
Treating PMS/PMDD--Research versus Clinical Reality$153,738
R21 · FY2001 · MH
ANXIETY, DISINHIBITION, AND RISK FOR DRUG ABUSE$210,302
R01 · FY2000 · DA
DETECTION AND TREATMENT OF POSTPARTUM DEPRESSION$151,653
K08 · FY2000 · MH
EFFECT OF SEROTONIN DEPLETION IN SEVERE PREMENSTRUAL SYNDROME$34,838
M01 · FY2000 · RR
IS FLUOXETINES ANTIDYSPHORIC EFFECT MEDIATED BY NEUROSTEROIDS?$0
M01 · FY2000 · RR